Вакансия из Hirify Global, списка международных tech-компаний Для мэтча и отклика нужен Plus
Пожаловаться
Зарплата и рынок
развернуть
$164к-246к/год
$200к$250кмедиана$280к
По похожим ролям (49) ~ $250к/год
85
Хорошая вакансия
развернуть
Company hidden предлагает руководящую научную роль в известной биофармацевтической компании с четкой ответственностью за исследования в нейронауке и редких заболеваниях; узкая специализация и ограничение по США сужают круг тех, кому подойдет эта возможность.
Подробное описание
Исследования редких болезней
?Командировки
Мэтч & Сопровод
Для мэтча с этой вакансией нужен Plus
Подключить Plus
Описание вакансии
Текст:
Hirify AI/Оригинал
TL;DR
Associate Director, In Vitro Neuropharmacology & Research Team Leader (RTL) (Neuropharmacology): Leading early-stage neuroscience drug discovery programs and developing quantitative in vitro pharmacology strategies for epilepsy and rare monogenic neurological disorders with an accent on molecular neuropharmacology, E/I biology, genotype-phenotype characterization, and candidate nomination. Focus on designing screening cascades, directing external CRO and ARO research, translating cellular findings to in vivo outcomes, and defending program strategy before governance and regulatory stakeholders.
Location: US - Home-Based, United States of America; Remote. Periodic travel of approximately 15–20% is required for headquarters meetings, governance sessions, scientific congresses, and vendor/CRO audits.
Base pay: $164,000–$246,000 per year for US-based candidates only; additional bonus, equity, and benefits may apply.
Company
hirify.global is a global biopharmaceutical company developing medicines for serious diseases, with research and development activities in oncology and neuroscience.
What you will do
Lead multidisciplinary early-stage neuroscience discovery programs as Research Team Leader from pre-DP0 through candidate nomination and IND/CTA-enabling transition.
Direct in vitro neuropharmacology strategy focused on excitation/inhibition balance, epilepsy biology, rare monogenic disorders, genotype-phenotype relationships, and mutation-specific pharmacology.
Oversee target engagement, functional potency, efficacy, mechanism-of-action, assay development, miniaturization, validation, and in vitro-to-in vivo translation.
Manage CRO, ARO, biotech, and technology-partner relationships, including outsourcing budgets, SOWs, MSAs, technical transfers, data integrity, and quality control.
Author and review nonclinical reports and regulatory documents, represent programs at governance committees and regulatory interactions, and support due diligence and external scientific collaborations.
Requirements
Ph.D. in Neuroscience, Neuropharmacology, Cellular/Molecular Biology, Biochemistry, or a related life sciences discipline with 7+ years of direct post-graduate biotechnology or pharmaceutical industry experience in drug discovery; or an M.S. in a relevant discipline with 10+ years of pharmaceutical or biotechnology industry experience in neuroscience drug discovery.
Proven experience leading multidisciplinary drug discovery teams across Chemistry, Biology, DMPK, and Toxicology through lead optimization, candidate nomination, and IND-enabling studies.
Authoritative knowledge of cellular and molecular neuropharmacology, ion-channel biophysics, synaptic physiology, neural-network excitability, epilepsy, status epilepticus, and severe genetic encephalopathies.
Extensive expertise in rare monogenic neurodevelopmental targets, human genetic variants, predictive in vitro functional assays, and mutation-specific pharmacology.
Advanced experience designing and miniaturizing quantitative 96-, 384-, and 1536-well assays using luminescence, HTRF/TR-FRET, FLIPR, high-content imaging, automated electrophysiology, and radioligand binding.
Comprehensive understanding of nonclinical drug development, ICH/FDA/EMA guidelines, GLP principles, and IND/CTA nonclinical pharmacology requirements.
Ability to conduct daily business in English is required.
Nice to have
Experience with human iPSC-derived neurons and glia, patient-derived or CRISPR/Cas9-engineered lines, neural co-cultures, brain organoids/assembloids, MEA, or automated patch-clamp platforms.
Experience in manual or automated patch-clamp electrophysiology, synaptic plasticity, or slice neurophysiology.
Familiarity with ASOs, molecular glues, PROTACs, antibodies, or other CNS therapeutic modalities beyond traditional small molecules.
Culture & Benefits
Remote, home-based work environment with extensive virtual collaboration and digital project-management and data-analysis tools.
Periodic travel of approximately 15–20% is part of the role.
Benefits may include medical, dental, and vision insurance, 401(k) retirement savings, and flexible paid vacation.
Additional discretionary annual cash bonus or incentive compensation and potential equity grants may be available.
Будьте осторожны
Если работодатель просит войти в их систему, используя iCloud/Google, прислать код/пароль, запустить код/ПО, не делайте этого. Это мошенники. Обязательно жмите «Пожаловаться» или пишите в поддержку. Подробнее в гайде →